L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma

doi:10.3748/wjg.v12.i1.94

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2752)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

298

HTML

2123

Figures (1-1)

164

Tables (1-2)

167

Sum=2752

Jan 7, 2006 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 7, 2006; 12(1): 94-98
Published online Jan 7, 2006. doi: 10.3748/wjg.v12.i1.94

Full Size Figure Download Figure

Figure 1 L1 expression in pancreatic neuroendocrine tumours or carcinomas. Immunohistochemical staining was performed by peroxidase method using monoclonal antibody UJ.127 against L1. Poorly-differentiated L1-positive pancreatic neuroendocrine carcinomas (grade 2; A and B) were shown in comparison to well-differentiated L1-negative tumours (grade 1a; C and D). Peripheral nerves (arrows) stained in (C, D) served as internal positive controls (Magnification ×200 (A and C) and ×400 (B and C)).

Citation: Kaifi JT, Zinnkann U, Yekebas EF, Schurr PG, Reichelt U, Wachowiak R, Fiegel HC, Petri S, Schachner M, Izbicki JR. L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma. World J Gastroenterol 2006; 12(1): 94-98
URL: https://www.wjgnet.com/1007-9327/full/v12/i1/94.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i1.94